One of the top antitrust boutique firms in the country, Axinn
doesn't sacrifice quality for quantity. Three is the magic number
for this firm: three practice areas in Antitrust, Intellectual
Property and Litigation, and three locations in New York, Hartford
and Washington, DC.
From Big to Small
Axinn was founded in 1997 by three lawyers from Skadden Arps,
including Steve Axinn, the founder and chairman of Skadden's
antitrust department. They quickly attracted a select group of the
finest lawyers from other preeminent firms in three practice
areas--antitrust, intellectual property and high-stakes corporate
litigation--all experienced and successful in achieving their
clients' strategic objectives in a trial setting, government
regulatory setting or a negotiated or mediated setting.
Notwithstanding its boutique size, Axinn is called upon to handle
its clients' largest and most strategically important matters.
…But Not too Small
Axinn quickly rose to the ranks of the big firms, winning
clients such as Google, Thermo Fisher, Unilever, Johnson &
Johnson, Tyson, Ball, Hexcel, Silver Lake Partners, The Hartford,
over a dozen major pharmaceutical companies and over a dozen
institutional investors. Axinn also is on lists such as Chambers'
best New York firms for Antitrust and Connecticut firms for
Litigation, and The National Law Journal's "Mid-size Hot List."
Global Competition Review has recognized Axinn for its most
prestigious awards in recent years, including Firm of the Year -
Americas (global lead counsel in its representation of Ball Corp.
in its $6.8 billion acquisition of Rexam), Matter of the Year
(representing Google in the FTC's investigation of Google and
Motorola), Merger Control Matter of the Year (representing Google
in its $700 million acquisition of ITA Software) and Lawyer of the
Year (John Harkrider).
Stop the Presses
Axinn has played a starring role in many news-making cases. The
antitrust group recently represented Dell in their $67 billion
acquisition of EMC; Thermo Fisher in their $13.2 billion
acquisition of Life Technologies; Ball Corporation in their $6
billion acquisition of Rexam; and McKesson in their $3.4 billion
merger with Change Healthcare. It currently represents Independence
Blue Cross in perhaps the largest private treble damage class
action in the United States. Axinn also oversaw Google's $12.5
billion acquisition of Motorola Mobility.
The antitrust group isn't Axinn's only headline maker. The
firm's IP group have obtained: (1) a favorable Federal Circuit
decision on a novel double patenting legal issue that led to a
settlement that allowed for the marketing of the first generic
version of Tamiflu®; (2) a multi-million dollar jury
verdict in a medical device patent case involving a spinal implant;
and (3) the first-ever decision by a district court ordering FDA to
approve a generic version of a drug.
Axinn also represents clients in high-stakes corporate and other
commercial litigation. The firm has litigated and tried numerous
major cases in the financial services industry, including the
representation of insurance companies and other institutional
investors regarding investment products such as mortgage-backed
securities. In recent years, Axinn has defeated billions of dollars
in asserted liability for defendants and obtained a $375 million
settlement for a plaintiff in RMBS litigation. Axinn
represents many of the world's leading hedge fund, insurers,
private equity firms and mutual funds. It has devised
creative solutions for these clients that have earned them hundreds
of millions of dollars through litigation-based investor
strategies. Axinn lawyers have also successfully defended
these clients against class actions involving everything from
insurance coverage, auction rate securities, cybersecurity, data
breaches and health care financing, to cell phones, infant formula,
auto parts and cable television.